M
MacroGenics, Inc.
MGNX · NASDAQ · Healthcare · 268M
Closing price
$3.74
+5.35% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
4.2×
Enterprise value / EBITDAEV/EBITDA
-4.8×
Free cash flow yieldFCF yield
-35.1%
Return on equityROE
-134.2%
Operating margin
-48.7%
Net debt / EBITDAbalance-sheet strength
-0.8×
Interest coverage
-8.6×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.